Status:
COMPLETED
Study of Surgical Procedures for Treatment of Persistent Nasolacrimal Duct Obstruction in Children < 4 Years Old
Lead Sponsor:
Jaeb Center for Health Research
Collaborating Sponsors:
National Eye Institute (NEI)
Conditions:
Nasolacrimal Duct Obstruction
Eligibility:
All Genders
6-47 years
Brief Summary
The purpose of this study is: * To report the success proportions for the treatment of persistent nasolacrimal duct obstruction for three surgical procedures: balloon catheter dilation, nasolacrimal ...
Detailed Description
Nasolacrimal duct obstruction (NLDO) is a common ocular condition in the first year of life. As many as 95% of cases resolve spontaneously by one year of age. For those children in whom the condition ...
Eligibility Criteria
Inclusion
- Age 6 - \< 48 months
- Parent/guardian has the ability to complete a written questionnaire
- Onset of NLDO symptoms and/or signs prior to 6 months chronological age
- Presence of epiphora, increased tear film, and/or mucopurulent discharge in the absence of an upper respiratory infection or an ocular surface irritation
- Previous single failed simple probing procedure for nasolacrimal duct obstruction
- Investigator has determined the patient requires a second procedure for opening of the nasolacrimal duct
Exclusion
- History of nasolacrimal intubation, balloon catheter dilation, more than one simple probing, or dacryocystorhinostomy
- Glaucoma present
- Corneal surface disease
Key Trial Info
Start Date :
February 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT00315315
Start Date
February 1 2005
End Date
February 1 2008
Last Update
May 17 2012
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wilmer Eye Institute
Baltimore, Maryland, United States, 21287-9028
2
Family Eye Clinic
Lancaster, Pennsylvania, United States, 17601